Filing Flows

Filing Flows › Chiron Real Estate (XRN) › Q2 2026 › vs Q2 2025

Chiron Real Estate (XRN) Q2 2026 vs Q2 2025 (year over year)

Chiron Real Estate's revenue rose $1.8M (+5%) from $38.0M in Q2 2025 to $39.7M in Q2 2026. The biggest changes: Healthcare Real Estate Segment −$63K (-0.2%). Operating margin 74.8% against 78.4% (-3.6 pts).

Chiron Real Estate, Q2 2026: revenue $39.7M (+5% year over year), operating margin 74.8%, net earnings $63.3M, operating cash flow $22.6M. The chart draws each line against Q2 2025, the increases inside each band.

Chiron Real Estate: what changed, Q2 2026 vs Q2 2025Chiron Real Estate: what changed, Q2 2026 vs Q2 2025Other income, net$71.7MPre-tax earnings$71.7MNet earnings$64.1MWorking capital & other$63.5MMinority interests$7.6MOther operating costs$2.6MCosts & expenses$1.8MCapital expenditures$1.1MGeneral & admin−$804KFree cash flow (OCF − capex)−$647K

Margins

Q2 2026Q2 2025Change
Operating margin74.8%78.4%-3.6 pts
Net margin159.2%-2.1%+161.3 pts
Free cash flow margin49.1%53.1%-4.0 pts

Every line

LineQ2 2026Q2 2025Change%
Healthcare Real Estate Segment$37.9M$38.0M−$63K-0.2%
Revenue$39.7M$38.0M$1.8M+5%
Other income, net$42.6M−$29.2M$71.7M—
Operating profit$29.7M$29.8M−$40K-0.1%
Costs & expenses$10.0M$8.2M$1.8M+22%
Pre-tax earnings$72.3M$585K$71.7M124×
General & admin$5.2M$6.0M−$804K-13%
Other operating costs$4.8M$2.2M$2.6M+120%
Net earnings$63.3M−$800K$64.1M—
Minority interests$9.0M$1.4M$7.6M+549%
Depreciation$11.4M$11.3M$136K+1%
Share-based compensation$1.4M$1.7M−$350K-20%
Working capital & other$53.6M−$9.9M$63.5M—
Operating cash flow$22.6M$22.1M$418K+2%
Free cash flow (OCF − capex)$19.5M$20.2M−$647K-3%
Capital expenditures$3.0M$2.0M$1.1M+54%

Questions

How much did Chiron Real Estate's revenue grow year over year in Q2 2026?

Chiron Real Estate's revenue rose $1.8M (+5%) from $38.0M in Q2 2025 to $39.7M in Q2 2026.

What drove Chiron Real Estate's revenue change in Q2 2026?

Healthcare Real Estate Segment −$63K (-0.2%).

Q2 2026 results → · Compare in the interactive Sankey →